Sarah Morgan
Director of Client Services

Sarah oversees strategic and creative direction for clients at Schering-Plough Corporation and Genentech. Sarah's expertise spans a variety of therapeutic categories, including allergy, cardiology, dermatology, oncology, neonatology and addiction therapy. In addition, she supports the agency's new-business initiatives, manages the agency's online presence and serves as the in-house specialist on design and new media.

In addition to managing broadcast and print media-relations campaigns, as well as consumer and professional disease-awareness programs, Sarah helps clients develop and strengthen partnerships with patient-advocacy organizations. Her work as a liaison with the National Psoriasis Foundation has provided beneficial media attention for all organizations involved. She also helped create the Colon Cancer Alliance's national Roots of Support patient-education program on behalf of Bristol-Myers Squibb and ImClone Systems.

Sarah has supported brands including: INTEGRILIN® for acute coronary syndrome for Schering-Plough; Taclonex® for psoriasis for Warner Chilcott; and Erbitux® for colorectal cancer (Bristol-Myers Squibb and ImClone Systems). She has supported pre-approval communications for Schering-Plough's SCH530348 for acute coronary syndrome, as well as Discovery Laboratories' Surfaxin® for neonatal respiratory distress syndrome, and Signalife's Fidelity 100 cardiac monitor. During her tenure at MCS, Sarah also provided corporate communications to Pfizer through the design and development of product newsletters distributed to brand managers around the world.

Prior to joining MCS in 2003, Sarah managed employee communications at Johnson & Johnson's Janssen Pharmaceutica, including event planning, website management and executive speechwriting.

Sarah graduated summa cum laude from Fairleigh Dickinson University with degrees in English and communications, and received a master's degree in communications and media studies from Fordham University.